3 weeks Synchronoss (SNCR) Beats Stock Market Upswing: What Investors Need to KnowZacks

In the closing of the recent trading day, Synchronoss (SNCR) stood at $11.29, denoting a +1.35% change from the preceding trading day.

Dow Jones · Mobile · Nasdaq 100 · Tech

33 mins Apple Races to Develop More Conversational SiriYouTube X

39 mins OpenAI is eyeing a shot at 2 of Google’s most dominant territories: reportBusiness Insider X

3 hours Intuit (INTU) Q1 2025 Earnings Call TranscriptThe Motley Fool X

3 hours A 1,788% Return…By This Afternoon?InvestorPlace X

3 hours Trump Media hints at crypto trading, payments in TruthFi trademark filing Cointelegraph X

3 hours Nvidia earnings adjust chances for S&P 500 record yearTheStreet X

3 hours Sam Altman has an idea to get AI to ‘love humanity,’ use it to poll billions of people about their value systemsFortune X

3 hours Three mystery whales have each spent $10 billion-plus on Nvidia’s AI chips so far this yearFortune X

3 hours Microsoft’s AI agents: 4 insights that could reshape the enterprise landscapeVentureBeat X

3 hours US stock futures dip as Alphabet losses rattle tech, rate jitters persistInvesting.com X

4 hours Gene Munster Is Bullish, Talks About Pressure Points on Nvidia’s (NVDA) EarningsInsider Monkey X

4 hours Meta: The Open-Source AI Bet That Could Change The GameSeeking Alpha X

4 hours 2 Small Cap AI Revolution Stocks for Your Watch ListZacks X

5 hours The New York Times says OpenAI deleted evidence in its copyright lawsuitYahoo Finance X

5 hours Hewlett Packard Enterprise Company (HPE) Partners with Securiti to Advance Secure Generative AI Development with Private Cloud AI IntegrationInsider Monkey X

5 hours TD Cowen Raises Palo Alto Networks, Inc. (PANW) Price Target to $420, Citing Strong ARR Growth and AI-Driven InnovationsInsider Monkey X

5 hours Co-dev studio Blind Squirrel reveals in-house original IP CosmoronsVentureBeat X

5 hours Wells Fargo Boosts AppLovin Corporation (APP) Price Target to $360 on Strong AI-Driven Marketing Performance and Advertiser MomentumInsider Monkey X

5 hours Scotiabank Raises Fortinet, Inc. (FTNT) Price Target to $110, Highlighting AI-Driven Growth and Hardware Refresh CycleInsider Monkey X

5 hours Google’s Chrome spin out chapter will ‘blow over’, says Deepwater’s Gene MunsterYouTube X

5 hours Mizuho Securities Reiterates ‘Buy’ Rating on Five9, Inc. (FIVN) with $55 Target, Citing AI Momentum and Strategic GrowthInsider Monkey X

5 hours Prologis (PLD) Stock Drops Despite Market Gains: Important Facts to NoteZacks X

5 hours Kinder Morgan (KMI) Laps the Stock Market: Here’s WhyZacks X

5 hours Google Against The DoJ: Market OverreactsSeeking Alpha X

5 hours ‘Fast Money’ traders talks regulatory headwinds in the Big Tech spaceYouTube X

5 hours Why Is Moderna, Inc. (MRNA) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

5 hours Why Is BridgeBio Pharma, Inc. (BBIO) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours These Magnificent 7 Reports Impressed Investors: AMZN, TSLAZacks X

6 hours Is Your Board Ready for AI?Fortune X

6 hours Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Why Is Legend Biotech Corporation (LEGN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours This Gen-Z-Led Startup Just Raised $2.6 Million to Diagnose Parkinson’s Using AIInc.com X

6 hours Why Is Ionis Pharmaceuticals, Inc. (IONS) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Why Is CRISPR Therapeutics AG (CRSP) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?Insider Monkey X

6 hours Nvidia’s Stock Was Down Despite Its Amazing Earnings. Here’s What History Says Is Coming NextThe Motley Fool X

6 hours SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One BasketSeeking Alpha X

6 hours Will the DOJ’s proposal to break up Google survive the incoming administration?Fast Company X

6 hours Google’s search business is all about distribution. The DOJ wants to take this away, and it’s freaking investors out.Business Insider X

6 hours Nvidia’s Magic Fades | Bloomberg TechnologyYouTube X

6 hours OpenAI considers taking on Google with browser, the Information reportsInvesting.com X

6 hours Apple: Berkshire And Buffett Are Right – It’s Time To SellSeeking Alpha X

7 hours U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.06%Investing.com X

7 hours AI and cloud computing’s energy demands could delay clean energy transitionFast Company X

7 hours NVIDIA’s Earnings Are Out. Can The AI King’s Reign Continue?InvestorPlace X

7 hours What Trump’s presidency means for the future of AIBusiness Insider X

7 hours Intuit quarterly earnings beats estimates on AI-driven tool demandInvesting.com X

More news +